Redcare Pharmacy NV (RDC.DE)
EUR 139.9
(-3.38%)
EUR 139.9
(-3.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.79 Billion | 1.2 Billion | 1.06 Billion | 968.06 Million | 701.01 Million | 539.71 Million |
| Cost of Revenue | 1.35 Billion | 872.56 Million | 793.79 Million | 748.53 Million | 563.32 Million | 440.39 Million |
| Gross Profit | 440.38 Million | 331.78 Million | 266.52 Million | 219.52 Million | 137.68 Million | 99.31 Million |
| Operating Expenses | 399.83 Million | 401.1 Million | 309.93 Million | 220.45 Million | 171.86 Million | 128.24 Million |
| Selling, General and Administrative Expenses | 444.48 Million | 244.23 Million | 196.88 Million | 145.23 Million | 108.71 Million | 81.41 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 190.24 Million | - | - | 65 Thousand | 136 Thousand | 196 Thousand |
| Cost and Expenses | 1.81 Billion | 1.27 Billion | 1.1 Billion | 968.99 Million | 735.19 Million | 568.63 Million |
| Operating Income | -16.73 Million | -69.17 Million | -65.69 Million | -866 Thousand | -33.44 Million | -28.73 Million |
| Interest Expense | 15.46 Million | 8.5 Million | 8.56 Million | 10.41 Million | 7.48 Million | 6.18 Million |
| Income Tax Expense | -2.74 Million | -6.47 Million | -3.69 Million | 839 Thousand | -5.91 Million | -982 Thousand |
| Earnings before Tax | -14.34 Million | -84.11 Million | -77.88 Million | -15.93 Million | -42.18 Million | -34.59 Million |
| Net Income | -12.04 Million | -77.64 Million | -74.18 Million | -16.77 Million | -36.27 Million | -33.6 Million |
| Earnings Per Share Basic | -0.63 | -4.32 | -4.15 | -1.17 | -2.78 | -2.79 |
| Earnings Per Share Diluted | -0.63 | -4.32 | -4.15 | -1.17 | -2.78 | -2.79 |
| Weighted Average Shares Outstanding | 19.23 Million | 17.98 Million | 17.88 Million | 14.37 Million | 13.06 Million | 12.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.23 Million | 17.98 Million | 17.88 Million | 14.37 Million | 13.06 Million | 12.04 Million |
| Gross Margin | 0.24 | 0.28 | 0.25 | 0.23 | 0.20 | 0.18 |
| EBIT Margin | 0.03 | -0.03 | -0.02 | 0.01 | -0.03 | -0.03 |
| Profit Margin | -0.01 | -0.06 | -0.07 | -0.02 | -0.05 | -0.06 |
| EBITDA | 58.17 Million | -30.64 Million | -37.41 Million | 14.65 Million | -19.83 Million | -16.32 Million |
| Earnings Before Tax Margin | -0.01 | -0.06 | -0.06 | -0.00 | -0.05 | -0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 560.67 Million | 560.21 Million | 1.79 Billion | 531.31 Million | 475.5 Million | 419.88 Million |
| Cost of Revenue | 446.61 Million | 445.65 Million | 1.41 Billion | 428.58 Million | 366.1 Million | 313.31 Million |
| Gross Profit | 114.05 Million | 114.56 Million | 383.09 Million | 102.73 Million | 109.4 Million | 106.57 Million |
| Operating Expenses | 117.24 Million | 120.32 Million | 399.83 Million | 126.38 Million | 111.52 Million | 108.84 Million |
| Selling, General and Administrative Expenses | 117.24 Million | 120.32 Million | - | 126.38 Million | 111.52 Million | 108.84 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 166 Thousand | 66 Thousand | - | - | 105 Thousand | 37 Thousand |
| Cost and Expenses | 563.86 Million | 565.97 Million | 1.81 Billion | 554.96 Million | 477.62 Million | 422.15 Million |
| Operating Income | -3.19 Million | -5.75 Million | -16.73 Million | -23.65 Million | -2.01 Million | -2.23 Million |
| Interest Expense | 3.81 Million | 4.25 Million | 15.46 Million | 4.17 Million | 3.74 Million | 3.68 Million |
| Income Tax Expense | -396 Thousand | -415 Thousand | -2.74 Million | -1.62 Million | -211 Thousand | -425 Thousand |
| Earnings before Tax | -5.18 Million | -8.6 Million | -14.57 Million | -8.08 Million | 8.89 Million | -4.49 Million |
| Net Income | -4.26 Million | -7.8 Million | -12.04 Million | -5.58 Million | 8.31 Million | -4.55 Million |
| Earnings Per Share Basic | -0.21 | -0.39 | - | -0.28 | 0.41 | -0.24 |
| Earnings Per Share Diluted | -0.21 | -0.39 | - | -0.28 | 0.41 | -0.24 |
| Weighted Average Shares Outstanding | 19.88 Million | 20.02 Million | 19.23 Million | 19.88 Million | 20.2 Million | 18.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.88 Million | 20.02 Million | 19.23 Million | 19.88 Million | 20.2 Million | 18.99 Million |
| Gross Margin | 0.20 | 0.20 | 0.21 | 0.19 | 0.23 | 0.25 |
| EBIT Margin | 0.02 | 0.02 | - | -0.01 | 0.06 | 0.03 |
| Profit Margin | -0.01 | -0.01 | -0.01 | -0.01 | 0.02 | -0.01 |
| EBITDA | 13.88 Million | 10.55 Million | - | -5.05 Million | 26.37 Million | 12 Million |
| Earnings Before Tax Margin | -0.01 | -0.01 | -0.01 | -0.04 | -0.00 | -0.01 |
PSG
TCNAF
0267
STGYF
688030
AREBW